Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors-Reference-Cited by-同舟云学术

Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors

Published:2020-08-29 Issue:9 Volume:29 Page:1059-1067
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Kim Seokuee¹,Kim Sujong²,Park Young Suk³,Park Joon Oh³,Lim Ho Yeong³,Ahn Jin Seok³,Lee Jeeyun³,Sun Jong Mu³,Kang Won Ki³,Han RaeO²,Kim Jungryul¹⁴^ORCID,Ahn Myung-Ju³

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Samsung Medical Center , Seoul, Republic of Korea

2. Pharmaceutical Division, Komipharm International Co., Ltd ., Siheung, Republic of Korea

3. Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Republic of Korea

4. Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University , Seoul, Republic of Korea

Funder

Komipharm International Co. Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2020.1804855

Reference24 articles.

1. Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

2. Induction of Centrosome Amplification during Arsenite-Induced Mitotic Arrest in CGL-2 Cells

3. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide

4. Effects of arsenic on telomerase and telomeres in relation to cell proliferation and apoptosis in human keratinocytes and leukemia cells in vitro

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of FNDC1 suppresses gastric cancer progression by interfering with Gβγ-VEGFR2 complex formation;iScience;2023-09

2. Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis;Toxicology and Applied Pharmacology;2022-04